Neuropsychiatric Immune-related Adverse Events Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma and Systemic Lupus Erythematosus

The patient was a 73-year-old woman with lung adenocarcinoma and systemic lupus erythematosus (SLE) who was treated with pembrolizumab. After six cycles of pembrolizumab, she developed symptoms suggestive of neuropsychiatric SLE, such as resting tremor, confusional state, depression, mood disorder,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Intern Med
Huvudupphovsmän: Jono, Misato, Kinehara, Yuhei, Utsu, Yoshihiko, Tamura, Yoshiro, Koseto, Masahiro, Murakami, Teruaki, Uota, Akifumi, Ninomiya, Ryusuke, Komo, Satoshi, Sumitani, Satoru, Sato, Bunzo, Kasayama, Soji, Tachibana, Isao
Materialtyp: Artigo
Språk:Inglês
Publicerad: The Japanese Society of Internal Medicine 2019
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7056375/
https://ncbi.nlm.nih.gov/pubmed/31666468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.3782-19
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk